Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Sucampo Pharmaceuticals, Inc. (SCMP): This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Sucampo Pharmaceuticals, Inc. Price and Consensus
Sucampo Pharmaceuticals, Inc. price-consensus-chart | Sucampo Pharmaceuticals, Inc. Quote
Bazaarvoice, Inc. (BV): This company that provides marketing tools to retailer and brand clients has seen the Zacks Consensus Estimate for its current year earnings increasing 37.5% over the last 60 days.Bazaarvoice, Inc. Price and Consensus
Bazaarvoice, Inc. price-consensus-chart | Bazaarvoice, Inc. Quote
Delek US Holdings, Inc. Price and Consensus
Delek US Holdings, Inc. price-consensus-chart | Delek US Holdings, Inc. Quote
Federated Investors, Inc. Price and Consensus
Federated Investors, Inc. price-consensus-chart | Federated Investors, Inc. Quote
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
Sucampo Pharmaceuticals, Inc. (SCMP): Free Stock Analysis Report
Federated Investors, Inc. (FII): Free Stock Analysis Report
Delek US Holdings, Inc. (DK): Free Stock Analysis Report
Cohu, Inc. (COHU): Free Stock Analysis Report
Bazaarvoice, Inc. (BV): Free Stock Analysis Report
Original post
Zacks Investment Research